✦ LIBER ✦

Initial Clinical Response Predicts Outcome and Is Associated With Dose Schedule in Metastatic Melanoma and Renal Cell Carcinoma Patients Treated With High-Dose Interleukin 2

✍ Scribed by Kathryn Spanknebel; Kenneth Y. Cheung; John Stoutenburg; Karl Hurst-Wicker; Charles Hesdorffer; Gail DeRaffele RN; and Howard L. Kaufman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initial clinical response predicts outco

✍ K. Spanknebel; K. Hurst-Wicker; Y. K. Cheung; C. Hesdorffer; G. DeRaffele; H. Ka 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 148 KB

High-dose interleukin-2 immunotherapy is

✍ JOHN P. BRUSKY; FAWEZ GAILANI; APURBA PATHAK; HATEL PATEL; SHERIF ABOSEIF 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Clinical outcome of combined immunothera

✍ Hideaki Miyake; Toshifumi Kurahashi; Atsushi Takenaka; Taka-aki Inoue; Masato Fu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Interleukin-2 dose, blood monocyte and C

✍ Gregers G. Hermann; Poul F. Geertsen; Hans von der Maase; Jesper Zeuthen 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 583 KB

Clinical and immunomodulatory effects of

✍ Jorge A. Garcia; Tarek Mekhail; Paul Elson; Pierre Triozzi; Cheryl Nemec; Robert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Clinical outcome and prognostic survival

✍ Minoru Kobayashi; Hitoshi Ikeda; Akinori Nukui; Kazumi Suzuki; Yasuhiro Sugaya; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 336 KB